JAYPIRCA (pirtobrutinib), FDA Approved for Treatment of Relapsed or Refractory Mantle Cell Lymphoma, Available at Biologics by McKesson
Biologics by McKesson was selected as a specialty pharmacy provider for JAYPIRCA, approved for adults with relapsed or refractory mantle cell lymphoma after at least two prior therapies.